NOWDx Test for the Detection of Antibodies to COVID-19 in Lay Persons

Stopped early · Not applicable

Conditions studied: COVID-19, SARS-CoV-2, Coronavirus

In brief

This study is designed to compare the performance of the NOWDx COVID-19 Test to an emergency use authorized PCR test result. The intent is to show the rapid test device is comparable to a currently marketed device. The NOWDx COVID-19 Test is an in vitro lateral flow immunoassay intended for qualitative detection of total antibodies to SARS-CoV-2 in human fingerstick whole blood at the Point of Care (POC); i.e. in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation; and at home.

Key facts

Study ID
NCT04799392
Run by
NOWDiagnostics, Inc.
People needed
50
Starts
2021-04-01
Expected to finish
2021-10-28
Last updated by the study team
2021-11-05

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.